Pulnovo Medical
Develops interventional therapies for pulmonary hypertension and heart failure
$100MStrategic
Role not disclosedLA
Lilly Asia Ventures
Activity from announced rounds
Activity in this selectionUndisclosed
- Rounds participated in
- 1
- Confirmed lead rounds
- — 1 roles undisclosed
- New companies
- 1 First participation on record · 0 follow-on
- Funding in participating rounds
- $100M 1 disclosed · full round size, not this investor’s share